Bio­gen re­veals plans for con­fir­ma­to­ry Aduhelm study, promis­ing re­sults in 5 years

For the first time, Bio­gen re­leased de­tails Thurs­day on how it in­tends to prove that its by turns cel­e­brat­ed and ma­ligned drug Aduhelm can ac­tu­al­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.